https://healthimpactnews.com/2022/38983-deaths-and-3530362-injuries-following-covid-shots-in-european-database-as-mass-funeral-for-children-who-died-after-pfizer-vaccine-held-in-switzerland/

歐洲（歐洲經濟區和非歐洲經濟區國家）疑似藥物反應報告的數據庫是 EudraVigilance，經歐洲藥品管理局 (EMA) 驗證，他們現在報告注射四次實驗性 COVID-19 疫苗後有 38,983 人死亡，3,530,362 人受傷：

總結受傷和死亡人數如下。 這是截至 2022 年 1 月 29 日的匯總數據。

疫苗來源

COVID-19 mRNA 疫苗 MODERNA (CX-024414)

COVID-19 mRNA 疫苗 PFIZER-BIONTECH

COVID-19 疫苗阿斯利康 (CHADOX1 NCOV-19)

COVID-19 疫苗詹森 (AD26.COV2.S)

從記錄的傷害總數來看，其中幾乎一半（1,672,872 人）是重傷。     “嚴重性是指以下情況；如果它導致死亡、危及生命、需要住院治療、導致另一種醫學上重要的疾病或延長現有住院時間、導致持續或嚴重殘疾或喪失能力的醫療事件，或者導致先天性異常/出生缺陷。則可以將其歸類為“嚴重” ” 歐洲的一位《健康影響新聞》訂閱者為我們在此處對包括四次 COVID-19 注射的每一種進行了報告。由於我們發現在 EudraVigilance 系統中沒有任何地方可以將所有結果製成表格，因此將每個反應與傷害和死亡情況製成表格需要做很多工作。 自從我們開始發布此內容以來，來自歐洲的其他人也計算了這些數字並確認了總數。* 疫苗分類報告： 1）  BioNTech/輝瑞公司的 mRNA 疫苗， Tozinameran（代碼 BNT162b2，Comirnaty）的總反應：，截至 29/01/2022 有 17,578 人死亡和 1,704,757 人受傷

以下各類副作用的症狀和人數

人數 副作用症狀 死亡人數

• 33,972   Injury, poisoning and procedural complications incl. 331 deaths

• 42,585   Investigations incl. 502 deaths

• 11,344   Metabolism and nutrition disorders incl. 273 deaths

• 201,643 Musculoskeletal and connective tissue disorders incl. 212 deaths

• 1,629     Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 153 deaths

• 278,744 Nervous system disorders incl. 1,859 deaths

• 2,513     Pregnancy, puerperium and perinatal conditions incl. 74 deaths

• 251        Product issues incl. 3 deaths

• 30,622   Psychiatric disorders incl. 207 deaths

• 6,150     Renal and urinary disorders incl. 266 deaths

• 68,129   Reproductive system and breast disorders incl. 6 deaths

• 72,531   Respiratory, thoracic and mediastinal disorders incl. 1,884 deaths

• 78,059   Skin and subcutaneous tissue disorders incl. 146 deaths

• 3,871     Social circumstances incl. 22 deaths

• 21,010   Surgical and medical procedures incl. 204 deaths

• 42,532   Vascular disorders incl. 766 deaths

2) Total reactions for the mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 11,008 deaths and 543,543 injuries to 29/01/2022

• 12,365   Blood and lymphatic system disorders incl. 120 deaths

• 18,287   Cardiac disorders incl. 1,142 deaths

• 190        Congenital, familial and genetic disorders incl. 11 deaths

• 6,310     Ear and labyrinth disorders incl. 8 deaths

• 502        Endocrine disorders incl. 6 deaths

• 7,475     Eye disorders incl. 36 deaths

• 44,340   Gastrointestinal disorders incl. 413 deaths

• 145,153 General disorders and administration site conditions incl. 3,630 deaths

• 793        Hepatobiliary disorders incl. 54 deaths

• 5,370     Immune system disorders incl. 22 deaths

• 23,070   Infections and infestations incl. 1042 deaths

• 10,286   Injury, poisoning and procedural complications incl. 208 deaths

• 12,129   Investigations incl. 393 deaths

• 4,847     Metabolism and nutrition disorders incl. 263 deaths

• 66,358   Musculoskeletal and connective tissue disorders incl. 223 deaths

• 682        Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 85 deaths

• 91,230   Nervous system disorders incl. 1,029 deaths

• 907        Pregnancy, puerperium and perinatal conditions incl. 10 deaths

• 98           Product issues incl. 4 deaths

• 9,441     Psychiatric disorders incl. 181 deaths

• 3,030     Renal and urinary disorders incl. 214 deaths

• 12,547   Reproductive system and breast disorders incl. 9 deaths

• 23,251   Respiratory, thoracic and mediastinal disorders incl. 1,162 deaths

• 27,540   Skin and subcutaneous tissue disorders incl. 96 deaths

• 2,239     Social circumstances incl. 45 deaths

• 3,028     Surgical and medical procedures incl. 203 deaths

• 12,075   Vascular disorders incl. 399 deaths

3) Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 7,977 deaths and 1,154,757 injuries to 29/01/2022

• 13,912   Blood and lymphatic system disorders incl. 278 deaths

• 20,984   Cardiac disorders incl. 830 deaths

• 235        Congenital familial and genetic disorders incl. 8 deaths

• 13,406   Ear and labyrinth disorders incl. 7 deaths

• 692        Endocrine disorders incl. 6 deaths

• 20,086   Eye disorders incl. 32 deaths

• 107,453 Gastrointestinal disorders incl. 434 deaths

• 304,993 General disorders and administration site conditions incl. 1,855 deaths

• 1,039     Hepatobiliary disorders incl. 69 deaths

• 5,409     Immune system disorders incl. 40 deaths

• 42,266   Infections and infestations incl. 620 deaths

• 13,630   Injury poisoning and procedural complications incl. 198 deaths

• 25,681   Investigations incl. 205 deaths

• 13,023   Metabolism and nutrition disorders incl. 126 deaths

• 168,174 Musculoskeletal and connective tissue disorders incl. 165 deaths

• 743        Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 40 deaths

• 234,117 Nervous system disorders incl. 1,178 deaths

• 635        Pregnancy puerperium and perinatal conditions incl. 20 deaths

• 199        Product issues incl. 1 death

• 21,051   Psychiatric disorders incl. 69 deaths

• 4,338     Renal and urinary disorders incl. 78 deaths

• 16,849   Reproductive system and breast disorders incl. 3 deaths

• 41,401   Respiratory thoracic and mediastinal disorders incl. 1,082 deaths

• 52,064   Skin and subcutaneous tissue disorders incl. 65 deaths

• 1,617     Social circumstances incl. 9 deaths

• 1,973     Surgical and medical procedures incl. 30 deaths

• 28,787   Vascular disorders incl. 529 deaths     

4) Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 2,420 deaths and 127,305 injuries to 29/01/2022

• 1,229     Blood and lymphatic system disorders incl. 51 deaths

• 2,552     Cardiac disorders incl. 204 deaths

• 40           Congenital, familial and genetic disorders incl. 1 death

• 1,319     Ear and labyrinth disorders incl. 3 deaths

• 105        Endocrine disorders incl. 1 death

• 1,656     Eye disorders incl. 10 deaths

• 9,588     Gastrointestinal disorders incl. 88 deaths

• 34,487   General disorders and administration site conditions incl. 685 deaths

• 153        Hepatobiliary disorders incl. 13 deaths

• 544        Immune system disorders incl. 10 deaths

• 8,521     Infections and infestations incl. 207 deaths

• 1,147     Injury, poisoning and procedural complications incl. 25 deaths

• 6,086     Investigations incl. 131 deaths

• 756        Metabolism and nutrition disorders incl. 60 deaths

• 17,116   Musculoskeletal and connective tissue disorders incl. 55 deaths

• 86           Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 8 deaths

• 23,413   Nervous system disorders incl. 245 deaths

• 55           Pregnancy, puerperium and perinatal conditions incl. 1 death

• 30           Product issues

• 1,766     Psychiatric disorders incl. 22 deaths

• 535        Renal and urinary disorders incl. 31 deaths

• 2,941     Reproductive system and breast disorders incl. 6 deaths

• 4,468     Respiratory, thoracic and mediastinal disorders incl. 304 deaths

• 3,760     Skin and subcutaneous tissue disorders incl. 10 deaths

• 409        Social circumstances incl. 4 deaths

• 867        Surgical and medical procedures incl. 74 deaths

• 3,676     Vascular disorders incl. 171 deaths

*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms.

還有圖片視頻無法上傳，感興趣者請自行點擊鏈接查閱